PG102 (Helixmith)

N/A

Report date: 2025/07/02 10:35:57
NME

Base Information

Drug NamePG102 (Helixmith)
Drug Alias NameHardy kiwi extract (PG102)​Th2 cytokine/IgE synthesis inhibitor (ViroMed)PG-102 (Helixir)PG-102THX-102 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunoglobulin E modulatorsT lymphocytes modulators
TargetsImmunoglobulin E
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHelixmith Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelixmith Co Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A